Call 1-888-587-7775


Prevention of Cross Transmission of Microorganisms Is Essential to Preventing Outbreaks of Hospital-Acquired Infections

Hospital-acquired infections (HAIs) are becoming increasingly common worldwide and occur during more than two million hospitalizations in the United States each year.

Due to an increase in invasive procedures and a growing resistance to antibiotics, HAIs have increased by 36% in the last 20 years and are consuming more health care dollars each year.

The burdens these infections place on our health care system can be divided into three categories: the cost of quality, the cost of human lives and the financial impact.

The human cost is over 99,000 deaths per year in the United States, which represents a 5% death rate for HAIs.

Quality costs include increased ICU stays by 8 days, and increased average hospital stay between 7.4 and 9.4 days.

Total dollar costs added to the health care system are between $4.5 and $5.7 billion annually, with the average cost per infection of $13,973 and an increased cost to patients (who survived) of approximately $40,000. Specifically, methicillin-resistant Staphylococcus aureus (MRSA) has become endemic, even epidemic in many U.S. hospitals, and added 2.7 million extra days in the hospital with an average cost of $35,367.

Where do the funds come from to pay for HAIs? Do they come from third-party payers, Medicare/Medicaid, hospitals, or patients? Haley et al analyzed 9,423 nosocomial infections and found that only 5-18% of nosocomial infections would have caused the admission to be reclassified to a higher diagnosis related group (DRG). Of those hospitalizations able to be reclassified to a higher DRG, the extra payment only funded 5% of the total cost to treat the infection. That leaves 95% of the financial burden of HAIs to hospitals and patients.

David Schwegman, MD., Assistant Professor of Medicine, Emory University

See entire article

Our Distributors

Our Associations

Our Testmonials

The IP-Pouch from Infection Prevention Products, Inc. is an amazing product. It has reduced respiratory infections immensely. I don't know how we've lasted this long without it.

Steve Tank
Director of Nurses
Country Villa Riverview

view all

Our Fans

About Infection Prevention Products

IPP focuses on simple yet effective methods to reduce Nosocomial infections in hospitals & care facilities. Our products have been tested in real life situations by the very nurses who have created them.

"Sometimes the questions are complicated and the answers are simple"

Get In Touch